These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24220143)

  • 1. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age.
    Hashemi S; Ramezani Tehrani F; Noroozzadeh M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():51-5. PubMed ID: 24220143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining hyperandrogenaemia according to the free androgen index in Chinese women: a cross-sectional study.
    Zhou Z; Ni R; Hong Y; Li Y; Wang Y; Zhao X; Yang D
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):446-52. PubMed ID: 22443308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age.
    Zhao X; He Z; Mo Y; Chen X; Chen Y; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):187-91. PubMed ID: 21111526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum androgen levels in elite female athletes.
    Bermon S; Garnier PY; Hirschberg AL; Robinson N; Giraud S; Nicoli R; Baume N; Saugy M; Fénichel P; Bruce SJ; Henry H; Dollé G; Ritzen M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4328-35. PubMed ID: 25137421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The age-associated decline of androgens in reproductive age and menopausal Black and White women.
    Spencer JB; Klein M; Kumar A; Azziz R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4730-3. PubMed ID: 17895325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women.
    Klein A; Stern N; Osher E; Kliper E; Kesler A
    Curr Eye Res; 2013 Sep; 38(9):972-6. PubMed ID: 23713489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism.
    Sütterlin M; Steck T
    Gynecol Endocrinol; 1995 Mar; 9(1):37-44. PubMed ID: 7793298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Two Statistical Methods to Determine Normal Range of Androgen Hormones: K-Means Cluster Analysis and Receiver Operating Characteristic Curve.
    Ramezani-Tehrani F; Rahmani K; Moradi A; Montazeri SA; Bidhendi-Yarandi R; Darabi F
    J Family Reprod Health; 2018 Jun; 12(2):96-102. PubMed ID: 30820213
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia.
    Misichronis G; Georgopoulos NA; Marioli DJ; Armeni AK; Katsikis I; Piouka AD; Saltamavros AD; Roupas ND; Panidis D
    Gynecol Endocrinol; 2012 Apr; 28(4):249-52. PubMed ID: 21970600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population.
    Maredia H; Lambert-Messerlian GM; Palomaki GE; Viali S; Hawley NL; McGarvey ST
    Clin Biochem; 2016 Jul; 49(10-11):782-6. PubMed ID: 26908216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity.
    Ivandić A; Prpić-Krizevac I; Sucić M; Jurić M
    Metabolism; 1998 Jan; 47(1):13-9. PubMed ID: 9440471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary testosterone may not serve as a screening test in the diagnosis of biochemical hyperandrogenism.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Kondracka A; Gajda S; Sieńko D
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1118-1125. PubMed ID: 29517119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.